Driving continuous improvements

Clinical development study teams must contend with many challenges and complexities in developing and executing clinical trials. We have deployed innovative solutions, and are developing various initiatives, to support our customers and their study teams.


These initiatives are categorized as:

Digital Innovation

At Q² Solutions, we have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. Using the Labmatrix® platform, a BioFortis (a Q² Solutions Company) technology, we’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency.


Learn more

Innovation Laboratories

In the summer of 2021, Q² Solutions opened a new state of the art, custom designed laboratory space, known as Q² Solutions Innovation Laboratories. Located on the new IQVIA Innovation Park Campus, in the heart of the dynamic Research Triangle Park in central North Carolina, this facility creates an innovative scientific community that includes multiple laboratory disciplines from service lines including Large Molecule Bioanalytical, Vaccines Center of Excellence, Genomics Center of Excellence and Translational Science and Innovation Laboratory (TSAIL).


Learn more

Digital Innovation

Related Thought Leaders Insights

Nexelis Marburg, Germany Laboratory

Located in the heart of Europe and led by Anne Katrin Hilbert, Managing Director, the Marburg laboratory maintains a staff of 90 specialists in a 25,000 square foot space. The facility operates under...

Through a CRO's Perspective: Innovative, Agile Solutions In Vaccine Efficacy Testing

The outbreak of the SARS-CoV-2 virus caused a sudden shift in focus for the pharmaceutical industry. After the genetic sequence of the virus was released in early 2020, manufacturers across the globe...

In vivo model design and assay selection to aid in progression from preclinical to clinical

Vaccine development is a complex path with multiple checkpoints and steps. In this presentation, we discuss the critical factors that must be assessed in the preclinical stage including: animal...